iCAD, Inc.
4 Townsend West
Suite 17
Nashua
New Hampshire
03063
United States
Tel: 603-882-5200
Fax: 603-880-3843
Website: http://www.icadmed.com/
335 articles about iCAD, Inc.
-
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
3/12/2024
iCAD, Inc. (NASDAQ: ICAD) today announced results for its fiscal fourth quarter and full year ended December 31, 2023, as compared to the corresponding period of the last fiscal year.
-
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
2/27/2024
iCAD, Inc. (NASDAQ: ICAD) announced today the Company will release financial results for the fourth quarter and full year 2023 financials after the market close, and host a conference call at 4:30 PM Eastern Time on Tuesday, March 12, 2024.
-
iCAD Expands Executive Sales Leadership Team as Business Grows
12/18/2023
iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice President, North American Sales and a role change for Bill Keyes to Senior Vice President, Global Sales Operations, both effective immediately.
-
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution
11/20/2023
iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and CancerIQ, the precision cancer prevention platform streamlining provider workflows and activating high-risk patients, announced a new partnership to create a best-in-class breast health care solution.
-
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
11/14/2023
iCAD, Inc. today announced that Dana Brown, President and Chief Executive Officer and Eric Lonnqvist, Chief Financial Officer, will participate at the 14th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16th.
-
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
10/30/2023
iCAD, Inc. today announced that it will release financial results for the third quarter ended September 30, 2023, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, November 13, 2023.
-
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
8/14/2023
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three and six months ended June 30, 2023.
-
iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader
8/14/2023
iCAD, Inc. announced it signed an amendment to its development and commercialization agreement with Google Health, which will enable iCAD to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D Mammography for use worldwide upon regulatory approval as an independent reader for breast cancer screening for 20 years.
-
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
7/31/2023
iCAD, Inc today announced it will release financial results for the second quarter of 2023 and host a conference call at 4:30 PM ET on Monday, August 14, 2023.
-
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
7/12/2023
iCAD, Inc today announced its “ProFound Insights, ProFound Impact” webinar series will feature Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic. Titled “How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most,” the live event will take place on Thursday, July 20 at 10 am ET.
-
iCAD Reports Financial Results for First Quarter Ended March 31, 2023
5/15/2023
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three months ended March 31, 2023.
-
iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End
3/28/2023
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and operating results for the twelve months ended December 31, 2022.
-
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023Company is exploring strategic options for its Therapy business line
3/13/2023
iCAD, Inc. today announced that it will release financial results for the fourth quarter and year ended December 31, 2022, after the market close, and host a conference call at 4:30 PM ET on Tuesday, March 28, 2023.
-
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
2/9/2023
iCAD, Inc. today announced the Company will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14-16, 2023 in Snowbird, UT.
-
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
1/23/2023
iCAD, Inc. today announced the Board of Directors has approved the appointment of Daniel Shea, CPA, as interim Chief Financial Officer (CFO), effective immediately.
-
iCAD Announces Board of Directors Transition
1/11/2023
iCAD, Inc. today announced the appointment of Dana Brown as Executive Chair of the Board of Directors.
-
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
12/8/2022
iCAD, Inc. will be featured in the next “ProFound Insights, ProFound Impact” webinar, on Dec. 14 at 3 pm EST / 12 pm PST.
-
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
11/21/2022
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of its Breast AI Suite will be highlighted at the Radiological Society of North America (RSNA) Annual Meeting in Chicago, November 27 to December 1.
-
iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference
11/15/2022
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th.
-
iCAD Reports Financial Results for Third Quarter Ended September 30, 2022
11/10/2022
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three and nine months ended September 30, 2022.